532 related articles for article (PubMed ID: 33691136)
1. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
Chiou SH; Tseng D; Reuben A; Mallajosyula V; Molina IS; Conley S; Wilhelmy J; McSween AM; Yang X; Nishimiya D; Sinha R; Nabet BY; Wang C; Shrager JB; Berry MF; Backhus L; Lui NS; Wakelee HA; Neal JW; Padda SK; Berry GJ; Delaidelli A; Sorensen PH; Sotillo E; Tran P; Benson JA; Richards R; Labanieh L; Klysz DD; Louis DM; Feldman SA; Diehn M; Weissman IL; Zhang J; Wistuba II; Futreal PA; Heymach JV; Garcia KC; Mackall CL; Davis MM
Immunity; 2021 Mar; 54(3):586-602.e8. PubMed ID: 33691136
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
Yang X; Chen G; Weng NP; Mariuzza RA
J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
[TBL] [Abstract][Full Text] [Related]
3. Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer.
Zhang B; Ren Z; Zhao J; Zhu Y; Huang B; Xiao C; Zhang Y; Deng J; Mao L; Tang L; Lan D; Gao L; Zhang H; Chen G; Luo OJ
Theranostics; 2023; 13(13):4449-4468. PubMed ID: 37649599
[No Abstract] [Full Text] [Related]
4. GPU-Accelerated Discovery of Pathogen-Derived Molecular Mimics of a T-Cell Insulin Epitope.
Whalley T; Dolton G; Brown PE; Wall A; Wooldridge L; van den Berg H; Fuller A; Hopkins JR; Crowther MD; Attaf M; Knight RR; Cole DK; Peakman M; Sewell AK; Szomolay B
Front Immunol; 2020; 11():296. PubMed ID: 32184781
[TBL] [Abstract][Full Text] [Related]
5. Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.
Grant EJ; Josephs TM; Valkenburg SA; Wooldridge L; Hellard M; Rossjohn J; Bharadwaj M; Kedzierska K; Gras S
J Biol Chem; 2016 Nov; 291(47):24335-24351. PubMed ID: 27645996
[TBL] [Abstract][Full Text] [Related]
6. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
[TBL] [Abstract][Full Text] [Related]
7. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
[TBL] [Abstract][Full Text] [Related]
8. Epitope distribution in ordered and disordered protein regions. Part B - Ordered regions and disordered binding sites are targets of T- and B-cell immunity.
Pavlović MD; Jandrlić DR; Mitić NS
J Immunol Methods; 2014 May; 407():90-107. PubMed ID: 24726865
[TBL] [Abstract][Full Text] [Related]
9. The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope.
Hoffmann TK; Loftus DJ; Nakano K; Maeurer MJ; Chikamatsu K; Appella E; Whiteside TL; DeLeo AB
J Immunol; 2002 Feb; 168(3):1338-47. PubMed ID: 11801674
[TBL] [Abstract][Full Text] [Related]
10. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Dietrich PY; Le Gal FA; Dutoit V; Pittet MJ; Trautman L; Zippelius A; Cognet I; Widmer V; Walker PR; Michielin O; Guillaume P; Connerotte T; Jotereau F; Coulie PG; Romero P; Cerottini JC; Bonneville M; Valmori D
J Immunol; 2003 May; 170(10):5103-9. PubMed ID: 12734356
[TBL] [Abstract][Full Text] [Related]
11. Functional detection of epithelial cell adhesion molecule specific cytotoxic T lymphocytes in patients with lung cancer, colorectal cancer and in healthy donors.
Trojan A; Tun-Kyi A; Odermatt B; Nestle FO; Stahel RA
Lung Cancer; 2002 May; 36(2):151-8. PubMed ID: 11955649
[TBL] [Abstract][Full Text] [Related]
12. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
Mami-Chouaib F; Echchakir H; Dorothée G; Vergnon I; Chouaib S
Immunol Rev; 2002 Oct; 188():114-21. PubMed ID: 12445285
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs.
Uemura Y; Senju S; Maenaka K; Iwai LK; Fujii S; Tabata H; Tsukamoto H; Hirata S; Chen YZ; Nishimura Y
J Immunol; 2003 Jan; 170(2):947-60. PubMed ID: 12517961
[TBL] [Abstract][Full Text] [Related]
15. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
Murata K; Nakatsugawa M; Rahman MA; Nguyen LT; Millar DG; Mulder DT; Sugata K; Saijo H; Matsunaga Y; Kagoya Y; Guo T; Anczurowski M; Wang CH; Burt BD; Ly D; Saso K; Easson A; Goldstein DP; Reedijk M; Ghazarian D; Pugh TJ; Butler MO; Mak TW; Ohashi PS; Hirano N
Elife; 2020 Apr; 9():. PubMed ID: 32314731
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
Front Immunol; 2019; 10():2076. PubMed ID: 31552033
[TBL] [Abstract][Full Text] [Related]
17. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
Harao M; Hirata S; Irie A; Senju S; Nakatsura T; Komori H; Ikuta Y; Yokomine K; Imai K; Inoue M; Harada K; Mori T; Tsunoda T; Nakatsuru S; Daigo Y; Nomori H; Nakamura Y; Baba H; Nishimura Y
Int J Cancer; 2008 Dec; 123(11):2616-25. PubMed ID: 18770861
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.
Bijen HM; van der Steen DM; Hagedoorn RS; Wouters AK; Wooldridge L; Falkenburg JHF; Heemskerk MHM
Mol Ther; 2018 May; 26(5):1206-1214. PubMed ID: 29567312
[TBL] [Abstract][Full Text] [Related]
19. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
[TBL] [Abstract][Full Text] [Related]
20. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire.
Lim A; Trautmann L; Peyrat MA; Couedel C; Davodeau F; Romagné F; Kourilsky P; Bonneville M
J Immunol; 2000 Aug; 165(4):2001-11. PubMed ID: 10925283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
